Lv13
38 积分 2023-01-04 加入
Antisense technology: an overview and prospectus
1天前
已完结
In vivo reduction of hepatitis B virus antigenemia and viremia by antisense oligonucleotides
1天前
已完结
In vivo reduction of hepatitis B virus antigenemia and viremia by antisense oligonucleotides
1天前
已完结
Highly sensitive detection of Epstein-Barr virus-infected cells by EBER flow FISH
2天前
已完结
Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial
7天前
已完结
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study
7天前
已完结
Control of Hepatitis B Virus with Imdusiran, a Small Interfering RNA Therapeutic
7天前
已完结
Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy
7天前
已完结
Hepatitis B virus biology and life cycle
8天前
已完结
In vivo reduction of hepatitis B virus antigenemia and viremia by antisense oligonucleotides
8天前
已完结
皖公网安备34019202002308
